ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO)

CUSIP: 00289Y206

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 6 signals
Share change
+1,866,203
SEC-reported price per share
$4.03
Number of holders
36
Value change
+$7,730,751
Number of buys
16
Number of sells
13
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
57,048,574

Security key

00289Y206

Report period

Q2 2023

Institutions

36

Top holders

10

Ownership snapshot

Top reported holders of ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Steven H. Rouhandeh
Disclosed value leader
Nantahala Capital Managem...
Comparable rows
0/15
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $4,028,864 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Nantahala Capital Management, LLC has the largest disclosed position value at $4.03M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nantahala Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
Steven H. Rouhandeh $2.73M
Nantahala Capital Management, LLC $4.03M
ADAGE CAPITAL PARTNERS GP, L.L.C. $3.75M
Point72 Asset Management, L.P. $3.24M
DEERFIELD MANAGEMENT COMPANY, L.P. $2.45M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Steven H. Rouhandeh
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$2,726,645
582,674 shares
mixed-class rows
— 25 May 2021
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$4,028,864
1,428,675 shares
— 31 Mar 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$3,753,871
1,331,160 shares
— 31 Mar 2023
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$3,244,827
1,150,648 shares
— 31 Mar 2023
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$2,452,173
869,565 shares
— 31 Mar 2023
Edward Carr
3/4/5
Chief Financial Officer
—
denominator unverified
$2,044,864
400,169 shares
— 08 Oct 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
36
Shares
9,392,092
Rows available
36
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
33
Q2 2023 holders
36
Holder diff
3
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .